On 29 July we hosted a practical discussion and Q&A on how clinical trials contribute to the development of treatments for Fragile X syndrome, and an overview of upcoming clinical trials in Australia.

The speakers are exceptionally well versed in Fragile X syndrome and the conduct of clinical trials, and are well known to many families.

Dr Honey Heussler,  Queensland Children’s Hospital
Michael Duhig, Clinical Research Manager at Queensland Children’s Hospital
Prof David Amor, Royal Children’s Hospital, Melbourne
Dr Natalie Silove, Westmead Children’s Hospital, Sydney for Q&A
Prof Ted Brown, President, FXAA

The recording of the webinar is now online: https://www.youtube.com/watch?v=ZxuuNgEYXXg

The webinar is hosted by Fragile X Association of Australia, and supported by Zynerba Pharmaceuticals.